Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2025
NUTEX HEALTH (NASDAQ: NUTX) appointed Wesley Bamburg as Chief Operating Officer, effective October 13, 2025. Bamburg brings 20 years of Fortune 500 healthcare experience and prior COO roles at HCA Houston Healthcare Medical Center (2019–2024) and HCA Houston Healthcare North Cypress (since July 2024).
The company said Bamburg's background in operations, payor contracting, integrated network management, and physician relations will support Nutex Health's physician-led micro hospital and outpatient expansion across 11 states.
NUTEX HEALTH (NASDAQ: NUTX) ha nominato Wesley Bamburg come direttore operativo (Chief Operating Officer), con effetto dal 13 ottobre 2025.
Bamburg porta 20 anni di esperienza nel settore sanitario Fortune 500 e precedenti ruoli di COO presso HCA Houston Healthcare Medical Center (2019–2024) e HCA Houston Healthcare North Cypress (da luglio 2024).
L'azienda ha dichiarato che l'esperienza di Bamburg in operazioni, contrattazione con i pagatori, gestione di reti integrate e relazioni con i medici sosterrà l'espansione di Nutex Health verso micro-ospedali e ambulatori guidati dai medici in 11 stati.
NUTEX HEALTH (NASDAQ: NUTX) nombró a Wesley Bamburg como Director Ejecutivo de Operaciones, con efecto a partir del 13 de octubre de 2025. Bamburg aporta 20 años de experiencia en el sector de la salud Fortune 500 y roles previos de COO en HCA Houston Healthcare Medical Center (2019–2024) y HCA Houston Healthcare North Cypress (desde julio de 2024).
La empresa afirmó que la experiencia de Bamburg en operaciones, contratación con pagadores, gestión de redes integradas y relaciones con médicos respaldará la expansión de Nutex Health hacia microhospitales y ambulatorios dirigidos por médicos en 11 estados.
NUTEX HEALTH (NASDAQ: NUTX)가 Wesley Bamburg를 최고운영책임자(COO)로 지명하며, 발효일은 2025년 10월 13일입니다.
Bamburg는 Fortune 500 헬스케어 분야에서 20년의 경험과 2019–2024년 HCA Houston Healthcare Medical Center, 2024년 7월 이후 HCA Houston Healthcare North Cypress에서의 COO 경력을 보유하고 있습니다.
회사는 Bamburg의 운영, 보험자 계약, 통합 네트워크 관리, 의사 관계 분야의 배경이 의사 주도 마이크로 병원 및 외래 진료 확장을 11개 주에 걸쳐 뒷받침할 것이라고 전했습니다.
NUTEX HEALTH (NASDAQ: NUTX) a nommé Wesley Bamburg au poste de directeur des opérations (COO), à effet du 13 octobre 2025.
Bamburg apporte 20 ans d'expérience dans le secteur de la santé Fortune 500 et des postes antérieurs de COO chez HCA Houston Healthcare Medical Center (2019–2024) et HCA Houston Healthcare North Cypress (à partir de juillet 2024).
L'entreprise a déclaré que l'expérience de Bamburg en opérations, en contractualisation avec les payeurs, en gestion de réseaux intégrés et en relations avec les médecins soutiendra l'expansion de Nutex Health vers des micro-hôpitaux et des services ambulatoires dirigés par les médecins dans 11 États.
NUTEX HEALTH (NASDAQ: NUTX) hat Wesley Bamburg zum Chief Operating Officer ernannt, wirksam ab dem 13. Oktober 2025.
Bamburg bringt 20 Jahre Fortune-500-Erfahrung im Gesundheitswesen sowie frühere COO-Rollen bei HCA Houston Healthcare Medical Center (2019–2024) und HCA Houston Healthcare North Cypress (seit Juli 2024) mit.
Das Unternehmen sagte, dass Bamburgs Hintergrund in Betrieb, Payor-Verträge, integriertes Netzwerkmanagement und Arztbeziehungen Nutex Health bei der ärztlich geleiteten Micro-Hospital- und Ambulant-Expansion in 11 Bundesstaaten unterstützen werde.
NUTEX HEALTH (NASDAQ: NUTX) عيّنت ويزلي بامبورغ في منصب الرئيس التنفيذي للعمليات (COO)، ويُطبق ذلك اعتباراً من 13 أكتوبر 2025.
يقدِّم بامبورغ خبرة عشرون عاماً في قطاع الرعاية الصحية ضمن شركات فورتشن 500 وأدوار COO السابقة في HCA Houston Healthcare Medical Center (2019–2024) وHCA Houston Healthcare North Cypress (منذ يوليو 2024).
قالت الشركة إن خلفية بامبورغ في العمليات والتعاقد مع الجهات الدافعة للتمويل وإدارة الشبكات المتكاملة والعلاقات مع الأطباء ستدعم توسع Nutex Health نحو مستشفيات micro- أو صغيرة تقودها الأطباء وعيادات خارجية في 11 ولاية.
- COO appointment of Wesley Bamburg effective Oct 13, 2025
- 20 years of Fortune 500 healthcare experience
- Prior COO roles at HCA from 2019–2024 and since July 2024
- None.
Mr. Bamburg is an accomplished healthcare executive with 20 years of Fortune 500 experience in healthcare operations, business development, integrated network management, and physician relations.
Mr. Bamburg has served as Chief Operating Officer for HCA Houston Healthcare North Cypress since July 2024. Before that, from 2019 to 2024, Mr. Bamburg was Chief Operating Officer at HCA Houston Healthcare Medical Center in
Mr. Bamburg began his career with HCA Healthcare in 2013 as the Gulf Coast Division's Vice President of Payor Contracting & Alignment. Prior to joining HCA Healthcare, Mr. Bamburg had the unique opportunity to lead large-scale initiatives in managed care, network operations, and physician alignment, cultivating a comprehensive viewpoint from both payor and provider experience across 11 states.
Mr. Bamburg attended Southwestern Oklahoma State University on an athletic scholarship, where he earned his Bachelor of Science in Healthcare Administration. He later earned a Master of Business Administration from
"The opportunity to join Nutex Health as COO is a tremendous honor. I have been deeply impressed by Nutex Health's innovative, physician-led model and its commitment to creating a more efficient and patient-centric healthcare experience," stated Mr. Bamburg, FACHE, Chief Operating Officer of Nutex Health. "I am excited to contribute to the company's dynamic growth and work alongside Dr. Vo and the entire team to shape the future of community-based hospital care."
"Wes will be a great addition to our very seasoned and close-knit team as we continue our mission of delivering accessible, concierge-level health care to communities across America," stated Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.
"We are thrilled to welcome Wes to the Nutex Health leadership team. His extensive experience in operations, payor contracting, and physician relations will be instrumental as we continue to expand our national footprint and strengthen our innovative healthcare delivery model," stated Jon Bates, MBA, CPA, Chief Financial Officer of Nutex Health.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 24 facilities in 11 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words or phrases "will," "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, to remediate our material weaknesses in a timely manner, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 8-K, filed on August 20, 2025, under the heading "Risk Factors" in Item 8.01 thereof, the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-announces-the-appointment-of-wesley-bamburg-as-its-new-chief-operating-officer-302562527.html
SOURCE Nutex Health, Inc.